BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16870110)

  • 1. Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies.
    Sangle SR; Jan W; Lau IS; Bennett AN; Hughes GR; D'Cruz DP
    Clin Exp Rheumatol; 2006; 24(3):349. PubMed ID: 16870110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuro-ophthalmologic aspects in antiphospholipid syndrome].
    Roşca T; Bontaş E; Bartoş D
    Oftalmologia; 2004; 48(2):65-70. PubMed ID: 15341103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-phospholipid syndrome nephropathy].
    Nochy D; Daugas E; Hill G; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification criteria for the antiphospholipid syndrome--the next modification].
    Zimmermann-Górska I
    Pol Arch Med Wewn; 2006 May; 115(5):396-400. PubMed ID: 17195350
    [No Abstract]   [Full Text] [Related]  

  • 6. On the catastrophic adjective for the antiphospholipid syndrome.
    Alarcon-Segovia D
    Clin Exp Rheumatol; 1993; 11(6):587-8. PubMed ID: 8093129
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and morphological characteristics of kidney pathology in antiphospholipid syndrome].
    Kalinina EE; Lesniak OM
    Ter Arkh; 2001; 73(12):88-91. PubMed ID: 11858121
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunopathology of the antiphospholipid syndrome].
    Stojanović Lj; Alekbergova Z; Kalasnikova Lj; Nasonov E; Manujlova L; Sokolov V; Stanić M
    Srp Arh Celok Lek; 1994; 122 Suppl 1():53-6. PubMed ID: 18173188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus.
    Alarcón-Segovia D; Estañol B; García-Ramos G; Villa AR
    Ann N Y Acad Sci; 1997 Aug; 823():279-88. PubMed ID: 9292055
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.
    Meyer O; Golstein M; Nicaise P; Labarre C; Kahn MF
    Clin Rev Allergy Immunol; 1995; 13(1):49-56. PubMed ID: 7648348
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Hawro T; Maurer M; Sysa-Jędrzejowska A; Woźniacka A
    Br J Dermatol; 2013 Jan; 168(1):213-5. PubMed ID: 22646136
    [No Abstract]   [Full Text] [Related]  

  • 12. Bithalamic stroke in a patient with systemic lupus erythematosus, positive antiphospholipid antibodies and warfarin use.
    Chang RS; Mak HK; Mak WW; Mok MY
    Int J Rheum Dis; 2012 Aug; 15(4):e76-7. PubMed ID: 22898232
    [No Abstract]   [Full Text] [Related]  

  • 13. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome].
    Alekberova ZS; Nasonov EL; Stoianovich LZ
    Ter Arkh; 1992; 64(5):77-9. PubMed ID: 1455383
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual vascular focal high-grade arterial stenoses in a young woman with systemic lupus erythematosus and secondary antiphospholipid syndrome.
    Hügli RW; Gremmelmaier D; Jeanneret C; Koella C; Jehle AW; Tyndall A; Biedermann BC
    Lupus; 2011 Mar; 20(3):311-4. PubMed ID: 21362753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stenosis in antiphospholipid syndrome: Update on the unrevealed mechanisms of an endothelial disease.
    Harifi G; Nour-Eldine W; Noureldine MHA; Berjaoui MB; Kallas R; Khoury R; Uthman I; Al-Saleh J; Khamashta MA
    Autoimmun Rev; 2018 Mar; 17(3):256-266. PubMed ID: 29339317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial antiphospholipid antibodies and acquired circulating anticoagulants.
    Elhajj I; Uthman I; Chahel A; Khoury F; Arayssi T; Taher A
    Lupus; 2004; 13(10):812-4. PubMed ID: 15540515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies.
    Paira SO
    J Rheumatol; 1998 Dec; 25(12):2476-7. PubMed ID: 9858454
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression.
    Hess DC; Sethi K; Awad E
    J Rheumatol; 1992 Sep; 19(9):1474-8. PubMed ID: 1433020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease.
    Amital H; Langevitz P; Levy Y; Afek A; Goldberg I; Pras M; Livneh A; Shoenfeld Y
    Clin Exp Rheumatol; 1999; 17(1):99-102. PubMed ID: 10084041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.